These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 583157
1. The influence of prenatal or neonatal administration of 2-bromo-alpha-ergocryptine on pituitary prolactin secretion and normal and neoplastic mammary growth in adult mice. Nagasawa H, Yanai R. J Endocrinol Invest; 1978 Jul; 1(3):273-6. PubMed ID: 583157 [Abstract] [Full Text] [Related]
2. Long-term effects of perinatal exposure to 5 alpha-dihydrotestosterone on normal and neoplastic mammary development in mice. Yanai R, Nagasawa H, Mori T, Nakajima Y. Endocrinol Jpn; 1981 Apr; 28(2):231-4. PubMed ID: 7308158 [Abstract] [Full Text] [Related]
4. Importance of progesterone in DNA synthesis of pregnancy-dependent mammary tumors in mice. Yanai R, Nagasawa H. Int J Cancer; 1976 Sep 15; 18(3):317-21. PubMed ID: 986372 [Abstract] [Full Text] [Related]
8. Interaction of estrogen and prolactin in spontaneous mammary tumorigenesis of the mouse. Welsch CW. J Toxicol Environ Health Suppl; 1976 Sep 15; 1():161-75. PubMed ID: 1036505 [Abstract] [Full Text] [Related]
9. Suppression of mammary tumorigenesis in C3H/He mice by ovariectomy or treatment with 2-bromo-alpha-ergocryptine: a comparison. Welsch CW, Lambrecht LK, Hassett CC. J Natl Cancer Inst; 1977 Apr 15; 58(4):1135-8. PubMed ID: 576623 [Abstract] [Full Text] [Related]
10. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine. Yanai R, Nagasawa H. J Natl Cancer Inst; 1970 Dec 15; 45(6):1105-12. PubMed ID: 5530649 [No Abstract] [Full Text] [Related]
11. Long-term effects of neonatal steroid exposure on mammary gland development and tumorigenesis in mice. Mori T, Bern HA, Mills KT, Young PN. J Natl Cancer Inst; 1976 Nov 15; 57(5):1057-62. PubMed ID: 187788 [Abstract] [Full Text] [Related]
12. Transplacental effects of diethylstilbestrol on mammary development and tumorigenesis in female ACI rats. Rothschild TC, Boylan ES, Calhoon RE, Vonderhaar BK. Cancer Res; 1987 Aug 15; 47(16):4508-16. PubMed ID: 3607779 [Abstract] [Full Text] [Related]
13. 17beta-oestradiol and Enovid mammary tumorigenesis in C3H/HeJ female mice: counteraction by concurrent 2-bromo-alpha-ergocryptine. Welsch CW, Adams C, Lambrecht LK, Hassett CC, Brooks CL. Br J Cancer; 1977 Mar 15; 35(3):322-8. PubMed ID: 576837 [Abstract] [Full Text] [Related]
14. Inhibition of mammary tumorigenesis in GR mice with 2-bromo-alpha-ergocryptine. Welsch CW, Goodrich-Smith M, Brown CK, Wilson M. Int J Cancer; 1979 Jul 15; 24(1):92-6. PubMed ID: 478693 [Abstract] [Full Text] [Related]
15. Irreversible inhibition of pituitary prolactin and growth hormone secretion and of mammary gland development in mice by monosodium glutamate administered neonatally. Nagasawa H, Yanai R, Kikuyama S. Acta Endocrinol (Copenh); 1974 Feb 15; 75(2):249-59. PubMed ID: 4406544 [No Abstract] [Full Text] [Related]
16. Long-term effects of perinatal exposure to hormones on normal and neoplastic mammary growth in rodents: a review. Mori T, Nagasawa H, Bern HA. J Environ Pathol Toxicol; 1979 Dec 15; 3(1-2):191-205. PubMed ID: 397957 [Abstract] [Full Text] [Related]
17. Prophylaxis of early preneoplastic lesions of the mammary gland. Welsch CW. Cancer Res; 1976 Jul 15; 36(7 PT 2):2621-5. PubMed ID: 1277169 [Abstract] [Full Text] [Related]